Novel delivery system of curcumin through transdermal route using sub-micronized particles composed of mesoporous silica and oleic acid

Journal of Functional Foods

Volumn 8, Issue 1, 2014, Pages 87-99

  Hamam, Fayez ^a   Al Remawi, Mayyas ^a  

^a TAIF UNIVERSITY   (Saudi Arabia)

Author keywords

Analgesic; Anti inflammatory; Curcumin; Mesoporous silica particles; Oleic acid; Transdermal

Indexed keywords

EID: 84899979718     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.03.006     Document Type: Article

References (58)

1. Al-Tahan F.J. Exploration of antinociceptive, antipyretic and anti-inflammatory activities of Curcumin in male rat. Iraqi Journal of Sciences 2012, 53:786-793.
2. Anand P., Thomas S.G., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Sung B., Tharakan S.T., Misra K., Priyadarsini I.K., Rajasekharan K.N., Aggarwal B.B. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochemical Pharmacology 2008, 76:1590-1611.
3. Arkan E. Modified silica sols as emulsifiers 2011, MS.c. thesis; 29-30.
4. Boelsma E., Boddé H.E., Ponec M. Assessment of the potential irritancy of oleic acid on human skin: evaluation in vitro and in vivo. Toxicology in Vitro 1996, 10:729-742.
5. Chen Y., Zhang Z., Yuan L., Liu X., Zhou L. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 2012, 171:5972-5987.
6. Cole G.M., Yang F., Teter B., Beguma A., Maa Q., Harris-White M.E., Frautschy S.A. Prevention of Alzheimer's disease: omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiology of Aging 2005, 26S:S133-S136.
7. Das R.K., Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine Nanotechnology Biological Medicine 2010, 6:153-160.
8. Dhillon N., Aggarwal B.B., Newman R.A., Wolff R.A., Kunnumakkara A.B., Abbruzzese J.L., Ng C.S., Badmaev V., Kurzrock R. Phase II trial of curcumin (diferuloyl methane), an NF-kB inhibitor, in patients with advanced pancreatic cancer. Journal of Clinical Oncology 2006, 24:14151-14156.
9. Durgaprasad S., Pai C.G., Kumar V., Alvres J.F., Namitha S. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. The Indian Journal of Medical Research 2005, 122:315-318.
10. Eddy N.B., Leimback D. Synthetic analgesics II dithienylbutenyl- and dithienylbutylamines. Journal of Pharmacology Experimental Therapy 1953, 107:385-393.
11. Fong C.H., Hasegawa S., Herman Z., Ou P. Limonoid Glucosides in Commercial Citrus Juices. Journal of Food Science 1989, 54:1505-1506.
12. Han Y.K., Jeong H.J., Kim M.S., Yoon M.H., Kim W.M. Analgesic effects of intrathecal curcumin in the rat formalin test. Korean Journal of Pain 2012, 25:1-6.
13. Hanai H., Iida T., Takeuchi K., Watanabe F., Maruyama Y., Andoh A. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clinical Gastroenterology and Hepatology 2006, 4:1502-1506.
14. He Q., Shi J. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. Journal of Materials Chemistry 2011, 21:5845-5855.
15. Holt P.R., Katz S., Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Digestive Diseases and Sciences 2005, 50:2191-2193.
16. Hu Y.C., Zhao Q., Wu C., Zhao P., Jiang H., Jiang T., Wang S. 3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol. Microporous and Mesoporous Materials 2012, 147:94-101.
17. Huang M.-T., Lysz T., Ferrara T., Abidi T.F., Laskin J.D., Conney A.H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Research 1991, 51:813-819.
18. Hussein G., Shah S.U., Shah K.U., Rahim N. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in vivo and ex vivo penetration of ketoprofen through rabbit skin. Pakistani Journal of Pharmaceutical Sciences 2012, 25:227-232.
19. Karthikesan K., Pari L., Menon V.P. Protective effect of tetrahydrocurcumin and chlorogenic acid against streptozotocin-nicotinamide generated oxidative stress induced diabetes. Journal of Functional Foods 2010, 2:134-142.
20. Kim M., Kim Y. Hypocholesterolemic effects of curcumin via up-regulation of cholesterol 7a-hydroxylase in rats fed a high fat diet. Nutrition Research and Practice 2010, 4:191-195.
21. Krishnakumar I.M., Ravi A., Kumar D., Kuttan R., Maliakel B. An enhanced bioavailable formulation of curcumin using fenugreek-derived soluble dietary fibre. Journal of Functional Foods 2012, 4:348-357.
22. Kunwar A., Barik A., Pandey R., Priyadarsini K.I. Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study. Biochimica et Biophysica Acta 2006, 1760:1513-1520.
23. Li L., Braiteh F.S., Kurzrock R. Liposome-encapsulated curcumin in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005, 104:1323-1331.
24. Li-duan Z., Qiang-song T., Cui-huan W. Growth inhibition and apoptosis inducing mechanisms of curcumin on human ovarian cancer cell line A2780. Chinese Journal of Integrative Medicine 2006, 12:126-131.
25. Loftsson T., Fridriksdótter H., Sugurdardóttir A.M., Thorkelsson J., Gudmundsson G., Hjaltason B. Fatty acids from cod-liver oil as skin penetration enhancers. Die Pharmazie 1995, 50:188-190.
26. Luz P.P., Magalhães L.G., Rodrigues V., Silva M.L.A. Curcumin-loaded into PLGA nanoparticles: preparation and in vitro schistosomicidal activity. Parasitology Research 2012, 110:593-598.
27. TM in traditional vehicles using non-everted rat intestinal sac model. Journal of Functional Foods 2010, 2:60-65.
28. Mahmoud N.N., Carothers A.M., Grunberger D., Bilinski R.T., Churchill M.R., Martucci C. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 2000, 21:921-927.
29. Moos P.J., Edes K., Mullally J.E., Fitzpatrick F.A. Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 2004, 25:1611-1617.
30. Narayanan B.A., Narayanan N.K., Davis L., Nargi D. RNA interference mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor. Molecular Cancer Therapeutics 2006, 5:1117-1125.
31. Nishikawa H., Tsutsumi J., Kitan S. Anti-inflammatory and anti-oxidative effect of curcumin in connective tissue type mast cell. Journal of Functional Foods 2013, 5:763-772.
32. Niu Y., Yang Q., Wang X., Chen Z., An X., Shen W. Temperature-dependent stability and DPPH scavenging activity of liposomal curcumin at pH 7.0. Food Chemistry 2012, 135:1377-1382.
33. Pantalei C., Andreani C., Sozzani P., Comotti A., Bracco S., Beretta M., Sokol P.E., Reiter G. Interaction of single water molecules with silanols in mesoporous silica. Physical Chemistry Chemical Physics 2011, 13:6022-6028.
34. Pawara Y.B., Valicherlaa G.R., Munjala B., Laleb S.V., Bansal A.K. Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach. International Journal of Pharmaceutics 2012, 436:617-623.
35. Popovaa M.D., Kolev I.N., Mihály J., Tzankovd B.S., Momekov G.T., Yoncheva K.P. Carboxylic modified spherical mesoporous silicas as drug delivery carriers. International Journal of Pharmaceutics 2012, 436:778-785.
36. Proctor A., Adhikari C., Blyhoder G.D. Lipid adsorption on commercial silica hydrogels from hexane and changes in triglyceride complexes with time. Journal of the American Oil Chemists' Society 1996, 73:693-698.
37. Sahu A., Kasoju N., Goswami P. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomaterialia 2008, 4:1752-1761.
38. Sajid P.A.R. Synthesis and characterization of silica nanocomposites for bone applications. International Research Journal of Pharmaceutics 2012, 3:173-177.
39. Sangsen Y., Likhitwitayawuid K., Sritularak B., Wiwattanawongsa K., Wiwattanapatapee R. Novel solid lipid nanoparticles for oral delivery of oxyresveratrol: effect of the formulation parameters on the physicochemical properties and in vitro release. International Journal of Medical Pharmaceutical Science and Engineering 2013, 7:506-513.
40. Sarawade P.B., Hilonga A., Kim H.T. Preparation of hydrophobic mesoporous silica powder with a high specific surface area by surface modification of a wet-gel slurry and spray-drying. Powder Technology 2010, 13:288-294.
41. Selvendiran K., Ahmed S., Dayton A., Kuppusamy M.L., Rivera B.K., Kálai T., Hideg K., Kuppusamy P. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. Cancer Biology and Therapy 2011, 12:837-845.
42. Sharma R.A., Gescher A.J., Steward W.P. Curcumin: the story so far. European Journal of Cancer 2005, 41:1955-1968.
43. Singh P.J.S.Y. Maryin's Physical Pharmacy and Pharmaceutical Sciences: Physical Chemical and Biopharmaceutical Principles in the Pharmaceutical Sciences 2011, Lippincott Williams & Wilkins, Philadelphia.
44. Som I., Yasir M. Status of surfactants as penetration enhancers in transdermal drug delivery. Journal of Pharmaceutics and Bioallied Sciences 2012, 4:2-9.
45. Sou K., Inenaga S., Takeoka S., Tsuchida E. Loading of curcumin into macrophages using lipid-based nanoparticles. International Journal of Pharmaceutics 2008, 325:287-293.
46. Sun M., He X., Liu X., Yu A., Lou H., Zhai G. Advances in nanotechnology-based delivery systems for curcumin. Nanomedincine 2012, 7:1085-1100.
47. Suzuki T. Formalin- and carrageenan-induced inflammation attenuates place preferences produced by morphine, methamphetamine and cocaine. Life Sciences 1996, 59:1667-1674.
48. Tamaddonfard E., Hamzeh-Gooshchi F., Hamzeh-Gooshchi N. Effect of curcumin on morphine-induced antinociception in acute corneal pain in rats. International Journal of Veterinary Research 2010, 4:127-131.
49. Tomren M.A., Loftsson T., Tønnesen H.H. Studies on curcumin and curcuminoids: XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. International Journal of Pharmaceutics 2007, 338:27-34.
50. Trebble T., Arden N.K., Stroud M.A., Wootton S.A., Burdge G.C. Inhibition of tumour necrosis factor-alpha and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. The British Journal of Nutrition 2003, 90:405-412.
51. Verma D.D.V., Blume G., Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. International Journal of Pharmaceutics 2003, 258:141-151.
52. Wang X., Wang Y.-W., Huang M.-T., Ho C.-T. Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chemistry 2008, 108:419-424.
53. Yadav A., Samim M., Flora S. Curcumin encapsulated in chitosan nanoparticles: a novel strategy for the treatment of arsenic toxicity. Chemico-Biological Interactions 2012, 199:49-61.
54. Yu H. Enhanced in vitro anti-cancer activity of curcumin encapsulated in hydrophobically modified starch. Food Chemistry 2010, 119:669-674.
55. Zhang F., Altorki N.K., Mestre J.R., Subbaramaiah K., Dannenberg A.J. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 1999, 20:445-451.
56. Zhang L., Hong-Chen G. Oleic acid coating on the monodisperse magnetic nanoparticles. Applied Surface Science 2006, 253:2611-2617.
57. Zhao X.-Z., Wang L., Yang H., Zhang S., Zhou P. Interaction of curcumin with Zn(II) and Cu(II) ions based on experiment and theoretical calculation. Journal of Molecular Structure 2010, 984:316-325.
58. Zhou H., Beevers C.S., Huang S. Targets of curcumin. Current Drug Targets 2011, 12:332-347.